Skip to main content
logo
Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
40.59
-0.41 (-1.00%)
At close: Mar 5, 2026, 4:00 PM EST
41.00
+0.41 (1.01%)
After-hours: Mar 5, 2026, 6:23 PM EST

Spyre Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
102
Market Cap
3.19B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023886.00K-1.44M-61.96%
Dec 31, 20222.33M-16.41M-87.57%
Dec 31, 202118.74M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Legend Biotech909.05M
Catalyst Pharmaceuticals588.99M
Tarsus Pharmaceuticals451.36M
Arcutis Biotherapeutics376.07M
IDEAYA Biosciences218.71M
Viridian Therapeutics70.85M
Liquidia69.22M
NewAmsterdam Pharma Company22.50M
Revenue Rankings

SYRE News

More News